Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
Clinical trial NCT00640601 · COMPLETED
Trial details
- NCT number
- NCT00640601
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2010-07-01
- Enrollment
- 331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.